Rebecca Robbins and Carl Zimmer
Posts
F.D.A. Authorizes Novavax’s Covid-19 Vaccine, a Latecomer
The vaccine was authorized as a primary immunization series for adults, rather than a booster, which may limit its market at first.
F.D.A. Authorizes Novavax’s Covid-19 Vaccine, a Latecomer
The vaccine was authorized as a primary immunization series for adults, rather than a booster, which may limit its market at first.
Merck’s Covid Pill Is Authorized by F.D.A. for High-Risk Adults
The F.D.A. said the drug should be prescribed mainly when other treatments were “not accessible or clinically appropriate.”
Merck's Covid Pill Cleared by FDA for High-Risk Adults
The F.D.A. said the drug was not a preferred treatment, but could be used when alternate treatment options were “not accessible or clinically appropriate.”
F.D.A. Clears Merck's Covid Pill for High-Risk Adults
The F.D.A. said the drug could be used when alternate treatment options were “not accessible or clinically appropriate.”
F.D.A. Clears Pfizer’s Covid Pill for High-Risk Patients 12 and Older
The first-of-its-kind treatment, Paxlovid, has been found to be highly protective against severe illness. It could be available within a few days.
Merck’s Covid Treatment Pill Wins Blessing of F.D.A. Panel
The treatment, known as molnupiravir, could be authorized in the United States within days, and available within weeks, if the F.D.A. follows the committee’s recommendation.